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Glucagon-like p ptide-1 (GLP-I) was purified to homogeneity b  HPLC and anion-exchange chromatography. A mole- 
cular mass of 3297.4 Da was obtained by FAB mass pectrometry which corresponded exactly to GLP-1 7-36 NH 2, pro- 
viding evidence that amidation occurs at an arginine residue during the post-translational processing ofGLP-1. The dis- 
tribution of GLP-1 7-36 NI-I2-1ike immunoreactivity (GLP-1 7-36 NH 2 IR) was determined in the rat gastrointestinal 
tract. Highest concentrations were found in terminal ileum and colon. Streptozocin-induced diabetic rats, who showed 
a significant increase infood intake, had a significant increase of GLP-1 7-36 NH 2 IR in the colon. 
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1. INTRODUCTION 
Mammalian proglucagon consists of 160 amino 
acid residues and is synthesized in the islets of 
Langerhans, intestine and brain [1,2]. As well as 
for glucagon, it also encodes for two glucagon-like 
peptides (GLP-1 1-37 or proglucagon sequence 
72-108, and GLP-2 or proglucagon sequence 
126-158) [3]. Paired basic amino acids were con- 
sidered to be the enzymatic cleavage points. 
However, the arginine residue at position 6 of 
GLP-1 was a possible monobasic leavage site [4]. 
The isolation and partial sequence analysis of the 
first 17 amino acids of pig intestinal GLP-1 con- 
firmed that cleavage does indeed occur at this 
residue 6 [5]. However, the proglucagon sequence 
104 to 110 is Val-Lys-Gly-Arg-Gly-Arg-Arg. Thus 
several molecular forms are possible at the C- 
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terminus of GLP-1, i.e." GLP-1 7-33, 7-34, 7-34 
NH2, 7-35, 7-36, 7-36 NH2 and 7-37. 
The aim of this study was therefore to purity rat 
intestinal GLP-1 and to determine its precise 
molecular weight by mass spectrometry and thus to 
deduce the sequence of the main naturally occur- 
ring molecular form. 
Synthetic GLP-1 7-36 NH2 greatly enhances 
glucose-induced insulin release in man at 
physiological concentrations and may be the most 
potent insulin-releasing hormone yet identified [6]. 
We therefore also determined the distribution of 
GLP-1 7-36 NH2-1ike immunoreactivity (GLP-1 
7-36 NH2 IR) in rat intestine of normal and of 
streptozocin-induced diabetic (STZ-D) rats, a com- 
monly employed experimental model of diabetes 
mellitus. 
2. MATERIALS AND METHODS 
2.1. Radioimmunoassay • 
GLP-1 7-36 NH2-1ike immunoreactivity (IR) and glucagon- 
like immunoreactivity (GLI) were measured asdescribed [6,7]. 
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The GLP-I 7-36 NH2 assay reacts 100% with GLP-1 1-36 
NH2. The GLI assay cross-reacts with glicentin and oxyn- 
tomodulin, the two main molecular forms of gut glucagon pro- 
cessing. 
2.2. Extraction of rat intestine 
Wistar rats (n = 6) (400-450 g) were killed by suffocation in 
a CO2 chamber. The colon and the distal half of the small in- 
testine were removed and cleaned with ice cold water. The tissue 
was then extracted in boiling water (500 ml) for 10 min. The 
supernatant was decanted and the tissue re-extracted with an 
equal volume of boiling 0.5 M acetic acid for a further 10 rain. 
The solutions were allowed to cool down, 25 g of diatomaceous 
earth (Sigma, Poole, England) added to each, then stirred, and 
passed through a Whatman filter paper size no. 113 (Whatman, 
Maidstone, England). Fractions (100 ml) of these solutions 
were then concentrated by passing through 5 activated C 18 
Sep-Pak cartridges (Waters Associates, Milford, MA, USA), 
connected in series, and eluted with 10 ml of 60% acetonitrile 
(ACN) (v/v). The eluents from both water and acid extract were 
pooled together separately and lyophilised. 
2.3. Chromatography 
Before each chromatographic step, the samples were cen- 
trifuged for l0 min at 11300 x g in a microcentrifuge. The first 
chromatographic step utilised a poly fluorocarbon column 
(Poly F ® , Du Pont, Stevenage, England) on a high pressure 
liquid chromatography (HPLC) system (Waters Associates) 
with a gradient from 0-60% solvent B (solvent A: H20/0.1% 
TFA; solvent B: ACN/0.1% TFA). The flow rate was 1 ml/min 
and 2 rain fractions were collected. 
The fractions showing GLP-1 7-36 NH2 IR were pooled 
together, lyophilised and reconstituted in buffer A for the 
anion-exchange chromatography. This was carried out on a 
FPLC system (Pharmacia, Milton Keynes, England) with a 
Mono Q column (HR 5/5) (buffer A: 25% aqueous 
ACN/20 mmol ethanolamine, pH 9.5; buffer B: buffer A plus 
1 M NaCl, pH 9.5). Acid and water extracts were run separate- 
ly. The flow rate was 1 ml/min and 2 min fractions were col- 
lected. The peak fraction of GLP-I 7-36 NH2 IR from the 
water and acid extracts were pooled together and dried down to 
a final volume of 0.5 ml before re-injection onto a Pep RPC 
C~s reverse-phase column (Pharmacia) on a FLPC system. A 
mixture of isocratic and linear gradient of solvent B 
(ACN/0.1% TFA) in solvent A (H20/0.1% TFA) was used: 
0-10 min: 0-20%; 10-130 min: 20-30%; 130-190 rain: 
isocratic 30%; 190-310 min: 30-40%; 310-330 rain: 40-60%. 
The final purification was monitored by UV absorption at 
214 nm. 
2.4. Mass spectrometry 
The analysis was carried out at M-Scan Ltd, Ascot, England. 
The sample was dissolved in 5% aqueous acetic acid and 2/zl 
were loaded onto a stainless steel FAB target previously 
smeared with 2-4/zl of meta-nitrobenzyl alcohol. Fast atom 
bombardment analysis was carried out as described in [8] on a 
M-Scan's VG Analytical ZAB high field mass spectrometer 
operating at Vacc = 8 kV for 15000 mass range at full sensitivi- 
ty. A cesium ion gun operating at 30 kV was used to generate 
spectra which were recorded using a PDP 11-250 J data 
system. Calibration was carried out using cesium iodide. 
2.5. STZ-D rats 
Male Wistar rats (n = 25) weighing 190-230 g were fed stan- 
dard rat food (PRD pellets, Labsure, London, England) and 
water ad libitum. One group (n = 13) received STZ (55 mg/kg 
in 0.2 ml buffer, Upjohn, Kalamazoo, MI, USA) and the other 
12, acting as control animals, were given 0.2 ml isotonic saline 
and sodium citrate solution at the same time. Eight weeks after 
inducing diabetes mellitus the rats were exsanguinated by car- 
diac puncture while under light ether anaesthesia. Blood was 
collected into fluoride oxaiate tubes for measurement of plasma 
glucose concentration bya glucose oxidase-based autoanaiyzer. 
The gut was removed, dissected, and cleaned with ice cold water 
and extracted in boiling 0.5 M acetic acid (10 vol per g wet wt 
tissue). Tissue extracts were subjected to anion-exchange 
chromatography on the above described system with a linear 
gradient of 0-20% buffer B (buffer A: 0.02 M ethanolamine 
and 0.1% polyoxyethylene sorbitan mono-oleate, pH 9.5; buf- 
fer B: buffer A plus 1 M NaCI) over 60 min at a flow rate of 
1 ml/min. 
2.6. Statistical nalyses 
Results were expressed as mean and standard error of the 
mean and statistical significance analysed by unpaired Student's 
t-test. P values of <0.05 were considered statistically 
significant. 
3. RESULTS 
3.1. Purification and mass spectrometry 
The resul ts  o f  the  pur i f i ca t ion  procedures  are  
shown in f ig.1.  A s ingle peak  o f  GLP-1  7 -36  NH2 
IR  e luted f rom the  Po ly  F co lumn (fig. 1A) and  was 
fu r ther  pur i f ied  by  an ion-exchange chromatog-  
raphy .  An ion-exchange chromatography  gave 
s imi la r  pro f i les  fo r  both  water  and  ac id  ext racts  
( f ig . lB ) .  The  peak  f rac t ions  were there fore  run  
together  for  the  f ina l  pur i f i ca t ion  by  HPLC.  The  
major  peak  a f te r  HPLC on  a Pep  RPC C-18 
co lumn conta ined  93°70 o f  the  GLP-1  7 -36  NH~ IR  
( f ig . lC ) .  A second peak  w i th  a 15 min  longer  
re tent ion  t ime cor responded to 3.5°7o (fig. 1C). The  
remain ing  GLP-1  7 -36  NH2 IR  e luted in 6 smal l  
peaks  (<0.3  pmol / tube)  w i th  re tent ion  t imes  be- 
tween 151 and  192 min .  
The  FAB mass  spect rometry  o f  the  major  peak  
gave  a molecu lar  mass  o f  3297.4 + 1 Da  cor-  
respond ing  exact ly  to the  molecu lar  mass  o f  
GLP-1  7 -36  amide .  Due  to  the  low amounts  o f  
mater ia l  in the  o ther  f rac t ions  we were unab le  to  
obta in  re l iab le  m/z  rat ios  for  them.  
3.2. STZ-D rats 
The body  mass  o f  the  STZ-D rats  was 
s ign i f i cant ly  decreased  (STZ-D rats:  288 _+ 12 g, 
cont ro l :  387 + 7 g; P < 0.001)  whereas  food  in take  
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Fig.1. Profiles of GLP-1 7-36 NHz IR during the purification 
procedures. Details of each chromatographic step are described 
in section 2. (A) HPLC with a Poly F column. (B) Anion- 
exchange chromatography. (C) HPLC with a PEP RPC C-18 
column. 
Fig.2. GLP-1 7-36 NH2 IR profiles after anion-exchange 
chromatography of  ileal and colonic extracts of STZ-D rats and 
control rats. The arrows indicate the retention times of 
synthetic GLP-I 7-36 NH2 and GLP-1 1-36 NH2, run under 
identical conditions. 
Table I 
Absolute (pmol/g wet wt) and relative concentration (pmol/g wet wt per 100 g body weight) 
of GLP-I  7-36 NH2 IR and GLI in gut of STZ-D rats (n = 13) and normal rats (n = 12) 
Stomach Upper small Terminal Colon 
intestine ileum 
GLP-1 7-36 NH2 IR 
(pmol/g) 
Control 0.3 + 0.05 
STZ-D rats 0.4 + 0.05 
(pmol/g per 100 g body wt) 
Control 0.08 + 0.01 
STZ-D rats 0.14 + 0.01 
GLI 
(pmollg) 
Control 0.6 ± 0.04 
STZ-D rats 0.8 ± 0.I 
(pmol/g per I00 g body wt) 
Control 0.2 ± 0.01 
STZ-D rats 0.3 + 0.02 
5 .4+0.4  188 + 10 100+ 10 
3.8_+ 0.3 171 + 9.8 136+ 9.7* 
1.4=1= 0.1 48.6+ 4.4 26 + 2 
1.3 + 0.1 59.3 + 5.6 47 + 4.3* 
8.1 + 0.4 247 + 14 144 + 10 
7 .0+0,6  239 + 10 212+ 15" 
2.1 + 0.2 63 + 5.9 37 + 3.1 
2.4 + 0.2 82 + 7.6 73 + 6.5* 
* P< 0.02 
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and non-fasted plasma glucose concentrations 
were significantly increased (food intake (g/day 
per rat)" STZ-D rats: 49 + 2; control: 35 ___ 3; 
glucose (mmol/l)" STZ-D rats: 28.3, control: 8.6 + 
0.2; P < 0.001). In both the STZ-D rats and the 
normal controls highest concentrations of GLP-1 
7-36 NH2 IR and GLI  were found in the terminal 
ileum (table 1). A significant increase of colonic 
GLP-1 7-36 NH2 IR and GLI was observed in the 
diabetic rats compared to the normal controls, 
whereas in the ileum, even when calculated relative 
to body mass, no significant change was found 
(table 1). Anion-exchange chromatography show- 
ed a similar profile of colonic and ileal tissue ex- 
tract of STZ-D rats and control rats (fig.2). The 
majority of the immunoreactive material eluted at 
the position of synthetic GLP-1 7-36 NH2. 
4. DISCUSSION 
The isolation and molecular mass determination 
of GLP-1 7-36 NH2 IR from rat intestine 
demonstrated for the first time that GLP-1 is in- 
deed C-terminal cleaved at the pairs of basic amino 
acids (proglucagon sequence 109, 110) and that the 
terminal glycine is processed to amidate the 
arginine residue. Only two similar arginine a- 
amidations have been reported so far: the pan- 
creatic GLP of anglerfish proglucagon and a 
highly active snake neurotoxin [9,10]. The dif- 
ferences in the molar content of gut GLI  and 
GLP-1 7-36 NH2 IR would indicate that not all 
GLP-1 of the intestine is processed to GLP-1 7-36 
NH2. In addition to detecting GLP-1 7-36 NH2 
several other minor  immunoreactive peaks were 
also detected. These indicate the presence of other 
molecular forms of GLP-1 albeit present in low 
concentrations. The low amount of immunoreac- 
tivity agrees with their corresponding small size of 
peak on the UV profile. It seems therefore very 
likely that GLP-1 7-36 NH2 is the major form pro- 
duced in the gastrointestinal tract. The increase of 
colonic GLP-1 7-36 NH2 IR and GLI  in the STZ- 
D rats may be due to hyperphagia nd the conse- 
quently increased food residue in the gut in this 
animal model of diabetes mellitus. Similar signifi- 
cant increases of GLI  have also been reported in 
hypothermia-induced hyperphagia rats and in lac- 
tating rats, another model of hyperphagia [11]. No 
change was observed in the processing of GLP-1 
7-36 NH2 between the diabetic animals and their 
controls. GLP-1 7-36 NH2 is a potent insulin- 
releasing hormone and it may be that the synthesis 
of proglucagon derived peptides in the gut is 
regulated by negative feedback mechanism in 
which diminished insulin levels result in increased 
synthesis of proglucagon in the intestine. 
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